Barrs Pharmaceuticals Secures R92m Hetero Investment
Barrs Pharmaceuticals has exited business rescue after agreeing to sell a controlling stake to Hetero. The deal signals a reset for a local manufacturer that has faced both operational disruption and regulatory pressure…. Membership Required You must be a member to access this content.View Membership LevelsAlready a member? Log in here...
HIV ARV Tender Crisis Triggers Parliamentary Scrutiny
South Africa faces an HIV ARV tender crisis as major suppliers enter business rescue, risking vital medicine availability.
WhatsApp Microlearning: Solving a Persistent HIV Training Gap
WhatsApp Microlearning helps clinics deliver quick, practical HIV policy updates, improving guideline uptake and service delivery.
ARV Supply Reassurance After Business Rescue Reports
SA's ARV Supply remains stable after two tender suppliers entered business rescue and contingency plans were put in place.
Pharma Giants Sidelined in R15.5bn HIV Drug Tender
The recent R15.5 billion ARV tender sidelines Pharma Giants in South Africa, raising questions about local production support.
SA’s HIV success story creates new challenges
Explore SA's HIV success story: a transformative treatment programme that increases life expectancy and faces new health challenges.